Molecular analysis of PinX1 in medulloblastomas

International Journal of Cancer

Volumn 109, Issue 2, 2004, Pages 309-314

  Chang, Qing ^a   Pang, Jesse Chung Sean ^a   Li, Jing ^b   Hu, Landian ^b   Kong, Xiangyin ^b   Ng, Ho Keung ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chromosome 8p; Medulloblastoma; Mutation; PinX1; Pseudogene; Telomerase activity

Indexed keywords

MESSENGER RNA; PINX1 PROTEIN, HUMAN; TELOMERASE; TUMOR SUPPRESSOR PROTEIN;

ADOLESCENT; ADULT; ALLELISM; ALTERNATIVE RNA SPLICING; ARTICLE; CARCINOGENESIS; CEREBELLUM TUMOR; CHILD; CHROMOSOME 8; CHROMOSOME ARM; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; EXON; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; METABOLISM; MUTATION; NEUROECTODERM TUMOR; NUCLEOTIDE SEQUENCE; PINX1 GENE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MEDULLOBLASTOMA; MUTATION; NEUROECTODERMAL TUMORS, PRIMITIVE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE DELETION; TELOMERASE; TUMOR SUPPRESSOR PROTEINS;

EID: 1242342026     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11689     Document Type: Article

References (30)

1. Giangaspero F, Bigner SH, Kleihues P, Pietsch T, Trojanowski JQ. Pathology and genetics of tumors of the nervous system. Kleihues P, Cavenee WK, eds. Lyon: IARC, 2000. 129-37.
2. Heideman RL, Packer RJ, Albright LA, Freeman CR, Rorke LB. Principles and practice of pediatric oncology. Pizzo PA, Poplack DG, eds. New York: Lippincott-Raven, 1997, 651-6.
3. Reardon DA, Michalkiewicz E, Boyett JM, Sublett JE, Entrekin RE, Ragsdale ST, Valentine MB, Behm FG, Li H, Heideman RL, Kun LE, Shapiro DN, et al. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res 1997;57:4042-7.
4. von Deimling A, Fimmers R, Schmidt MC, Bender B, Fassbender F, Nagel J, Jahnke R, Kaskel P, Duerr EM, Koopmann J, Maintz D, Steinbeck S, et al. Comprehensive allelotype and genetic analysis of 466 human nervous system tumors. J Neuropathol Exp Neurol 2000; 59:544-58.
5. Yin XL, Pang JC, Ng HK. Identification of a region of homozygous deletion on 8p22-23.1 in medulloblastoma. Oncogene 2002;21:1461-8.
6. Eberhart CG, Kratz JE, Schuster A, Goldthwaite P, Cohen KJ, Perlman EJ, Burger PC. Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol 2002;12:36-44.
7. Saylors RL 3rd, Sidransky D, Friedman HS, Bigner SH, Bigner DD, Vogelstein B, Brodeur GM. Infrequent p53 gene mutations in medulloblastomas. Cancer Res 1991;51:4721-3.
8. Zurawel RH, Chiappa SA, Allen C, Raffel C. Sporadic medulloblastomas contain oncogenic beta-catenin mutations, Cancer Res 1998; 58:896-9.
9. Huang H, Mahler-Araujo BM, Sankila A, Chimelli L, Yonekawa Y, Kleihues P, Ohgaki H. APC mutations in sporadic medulloblastomas. Am J Pathol 2000;156:433-7.
10. Raffel C, Jenkins RB, Frederick L, Hebrink D, Alderete B, Fults DW, James CD. Sporadic medulloblastomas contain PTCH mutations. Cancer Res 1997;57:842-5.
11. Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, Zhang X, Agatep R, Chiappa S, Gao L, Lowrance A, Hao A, Goldstein AM, et al. Mutations in SUFU predispose to medulloblastoma. Nat Genet 2002;31:306-10.
12. Baeza N, Masuoka J, Kleihues P, Ohgaki H. AXIN1 mutations but not deletions in cerebellar medulloblastomas. Oncogene 2003;22: 632-6.
13. Yin XL, Pang JC, Liu YH, Chong EY, Cheng Y, Poon WS, Ng HK. Analysis of loss of heterozygosity on chromosomes 10q, 11, and 16 in medulloblastomas. J Neurosurg 2001;94:799-805.
14. Pang JC, Dong Z, Zhang R, Liu Y, Zhou L, Poon WS, Ng H. Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors. Int J Cancer 2003;105:76-81.
15. Wang JC, Radford DM, Holt MS, Helms C, Goate A, Brandt W, Parik M, Phillips NJ, DeSchryver K, Schuh ME, Fair KL, Ritter JH, Marshall P, Donis-Keller H. Sequence-ready contig for the 1.4-cM ductal carcinoma in situ loss of heterozygosity region on chromosome 8p22-p23. Genomics 1999;60:1-11.
16. Zhou XZ, Lu KP. The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell 2001;107:347-59.
17. Tian XX, Pang JC, To SS, Ng HK. Restoration of wild-type PTEN expression leads to apoptosis, induces differentiation, and reduces telomerase activity in human glioma cells. J Neuropathol Exp Neurol 1999;58:472-9.
18. Raff T, van der Giet M, Endemann D, Wiederholt T, Paul M. Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes. Biotechniques 1997;23:456-60.
19. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE, Shay JW. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Meth Cell Sci 1995;17:1-5.
20. Park WS, Lee JH, Park JY, Jeong SW, Shin MS, Kim HS, Lee SK, Lee SN, Lee SH, Park CG, Yoo NJ, Lee JY. Genetic analysis of the liver putative tumor suppressor (LPTS) gene in hepatocellular carcinomas. Cancer Lett 2002;178:199-207.
21. Prasad MA, Trybus TM, Wojno KJ, Macoska JA. Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site. Genes Chromosomes Cancer 1998;23:255-62.
22. Wistuba II, Behrens C, Virmani AK, Milchgrub S, Syed S, Lam S, Mackay B, Minna JD, Gazdar AF. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res 1999;59:1973-9.
23. Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev 2002;66:407-25.
24. Liao C, Zhao M, Song H, Uchida K, Yokoyama KK, Li T. Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma. Hepatology 2000;32:721-7.
25. Lin SY, Elledge SJ. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 2003;113:881-9.
26. DeMasters BK, Markham N, Lillehei KO, Shroyer KR. Differential telomerase expression in human primary intracranial tumors. Am J Clin Pathol 1997;107:548-54.
27. Sano T, Asai A, Mishima K, Fujimaki T, Kirino T. Telomerase activity in 144 brain tumours. Br J Cancer 1998;77:1633-7.
28. Sugita Y, Nakashima A, Kato S, Sakata K, Morimatsu M, Shigemori M. Telomerase activity in gliomas with the use of non-radioisotopic and semi-quantitative procedure for terminal repeat amplification protocol. Oncol Rep 2000;7:1087-92.
29. Cabuy E, de Ridder L. Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo. Virchows Arch 2001;439: 176-84.
30. Falchetti ML, Larocca LM, Pallini R. Telomerase in brain tumors. Childs Nerv Syst 2002;18:112-7.